Skip to main content

Achieve Life Sciences, Inc.

ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000949858

In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Achieve Life Sciences, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of ACHV: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders66660
Shares26.2M15.5M−10.7M (−40.8%)
Value$59.3M$48.9M−$10.4M (−17.5%)

New holders (22)

Institutions that held Achieve Life Sciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to ACHV in Q3 2025
InstitutionSharesValue% of portfolio
Marshall Wace, LLP774,853$2.44M0.00%
Pathstone Holdings, LLC502,000$1.58M0.01%
Two Sigma Investments, LP439,064$1.38M0.00%
Renaissance Technologies LLC310,764$978.9K0.00%
Two Sigma Advisers, LP110,300$347.4K0.00%
Ronald Blue Trust, Inc.99,130$312.3K0.00%
XTX Topco Ltd85,855$270.4K0.01%
Dimensional Fund Advisors LP52,420$165.1K0.00%
Cubist Systematic Strategies, LLC35,523$111.9K0.00%
Rockefeller Capital Management L.P.30,000$94.5K0.00%
Omers Administration Corp24,700$77.8K0.00%
Resources Investment Advisors, LLC.20,000$63.0K0.00%
Next Capital Management LLC16,130$50.8K0.02%
Robertson Stephens Wealth Management, LLC10,000$31.5K0.00%
Point72 Asia (Singapore) Pte. Ltd.7,505$23.6K0.00%
FNY Investment Advisers, LLC5,000$15.0K0.00%
Federation des caisses Desjardins du Quebec2,000$6.30K0.00%
Sittner & Nelson, LLC673$2.12K0.00%
Capital Analysts, LLC510$2.00K0.00%
Optiver Holding B.V.490$1.54K0.00%
Point72 (DIFC) Ltd189$5950.00%
SRS Capital Advisors, Inc.10$310.00%

Sold out (22)

Institutions that held Achieve Life Sciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.